Citations

Clear

361 citation(s) found for "Bauer, M".

The Rounds Efficiency Index: A Novel Physics-Based Construct for Patient- and Family-Centered Rounds
Tuomela, Krista, Agbeh, Abiye, Anibaba, Fatima, Toth, Heather, Rogers, Amanda , Porada, Kelsey , Lynch, Kelly, Hadjiev, Jennifer , Weisgerber, Michael , Bauer, Sarah Corey

Mayo Clinic

Hospital Pediatrics | June 6, 2024 | Volume: 14 | Issue: 7 | Pages: 584-591

10.1542/hpeds.2022-006971 | PMID 38841773 Get It

BACKGROUND AND OBJECTIVES Efficiently conducting patient- and family-centered rounds (PFCR) is challenging, particularly without a measure of efficiency. In physics, efficiency is the ratio of work output to work input. We sought to evaluate PFCR efficiency via a novel construct rooted in physics. Our objectives were to (1) Establish baseline work output for clinical work (CW), educational effectiveness (EE), and family experience (FE); (2) establish baseline work input for rounds length (RL); and (3) begin preliminary construction of a rounds efficiency index (REI) as a measure of PFCR efficiency. METHODS Four components of rounds efficiency were collected on 5 inpatient acute care teams during a baseline period. CW consisted of the percentage of daily orders placed on rounds. EE was assessed via survey for trainees and FE by families. RL was recorded in minutes per patient. During an 8-week intensive period, the REI (reported as %) was calculated as a ratio of work output/work input using aggregate mean/median ratings for CW, EE, FE, and RL. RESULTS Baseline data included 809 orders, 28 EE ratings, 21 FE ratings, and RL mean of 11.4 minutes per patient. During the intensive period, the median team-specific weekly REI for the end versus beginning of the academic year was 58% and 52.5% (P = .17), respectively. The median REI during the start and end of the block was 49% and 57% (P = .15), respectively. CONCLUSIONS The study assessed 4 components of efficiency (CW, EE, FE, RL) and calculated REI allowing for a preliminary tool to measure rounding efficiency. With this, targeted interventions can improve PFCR efficiency.
Peak study: A phase 3, randomized, open-label multi-center clinical study of bezuclastinib (CGT9486) and sunitinib combination versus sunitinib in patients with gastrointestinal stromal tumors (GIST).
Tap, William D. , Somaiah, Neeta , Razak, Albiruni Ryan Abdul, Reichardt, Peter , Druta, Mihaela , Singh, Arun S. , Attia, Steven , Moynihan, Kevin, Lawrence, Julia, Wagner, Andrew J. , Kang, Yoon‐Koo , Garrido, Marcelo , Desar, Ingrid M.E. , Italiano, Antoîne , Wilky, Breelyn A , Heinrich, Michael C. , Bauer, Sebastian , Serrano, César , Trent, Jonathan C.

Mayo Clinic

Journal of Clinical Oncology | June 3, 2024 | Volume: 42 | Issue: 16_suppl | Pages: TPS11588-TPS11588

10.1200/jco.2024.42.16_suppl.tps11588 Get It

TPS11588 Background: Imatinib is the worldwide standard for first-line therapy of advanced KIT-mutant GIST. However, secondary resistance mutations in the KIT ATP-binding domain (exons 13, 14), activation loop (exons 17, 18), or both develop and result in loss of imatinib-sensitivity. Bezuclastinib has a highly selective inhibition profile, leading to minimal off-target toxicities and allowing for combination with sunitinib. While no single tyrosine kinase inhibitor (TKI) inhibits all KIT mutations, the combination of bezuclastinib + sunitinib targets commonly occurring primary (exons 9, 11) and secondary (exons 13, 14, 17, and 18) KIT mutations and may provide more durable responses. The early signs of clinical activity, tolerability, and safety observed with the combination thus far in Peak Part 1 (Somaiah et al. [presentation] CTOS 2023. Paper 62) are consistent with the completed Phase 1/2 study (PLX121-01). Methods: Peak (NCT05208047) is a global, randomized, open-label, multi-part Phase 3 study evaluating the efficacy and safety of bezuclastinib + sunitinib versus sunitinib as second-line treatment in adult pts who were intolerant to imatinib or whose tumors had imatinib-resistance. Current Peak study sites are located in North America (3 countries), South America (3 countries), Europe (12 countries), and Asia-Pacific (4 countries). The lead-in portion to test a new formulation of bezuclastinib, (Part 1) completed enrollment in April 2023. Based upon PK and safety, a dose of bezuclastinib 600 mg QD + sunitinib 37.5 mg QD was determined for Part 2 of the Peak study. Part 2 will enroll ~388 pts to be randomized (1:1) to bezuclastinib 600 mg QD + sunitinib 37.5 mg QD or sunitinib 37.5 mg QD alone. Key inclusion: >1 measurable lesion per modified Response Evaluation Criteria in Solid Tumors (mRECIST) v1.1, Eastern Cooperative Oncology Group Performance Status 0-2, adequate organ function, and prior imatinib therapy (no other prior therapy). Key exclusion: known PDGFR mutations or succinate dehydrogenase deficiency, clinically significant cardiac disease, and use of strong CYP3A4 inhibitors or inducers. The primary endpoint is progression-free survival (PFS) confirmed by blinded independent central review per mRECIST v1.1. Additional efficacy (including overall survival and objective response rate) and safety endpoints will be evaluated and circulating tumor DNA (ctDNA) will be collected and assessed. Clinical trial information: NCT05208047 .
Alterations in Kidney Venous Flow in the Prognosis of Heart Failure
Singam, Sharma, Viehman, Jason K., Schulte, Philip, Bauer, Pascall, Tello, Khodr , Richter, Manuel J. , Birk, Horst‐Walter, Husain‐Syed, Faeq , Bauer, Pascal , Seeger, Werner , Gall, Henning , Ghofrani, Hossein Ardeschir , Kashani, Kianoush , Ronco, Claudio

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 817-818

10.1681/asn.20223311s1817d Get It

Intubation in COVID-19: When Severity and Trajectory Collide*
Mongardon, Nicolas , Bauer, Philippe R.

Mayo Clinic

Critical Care Medicine | May 16, 2024 | Volume: 52 | Issue: 6 | Pages: 990-992

10.1097/ccm.0000000000006246 | PMID 38752819 Get It

Association Between Adjunctive Vasopressors and Short-term Mortality in Adults With Septic Shock: A Systematic Review and Meta-analysis
Turpin, Brittany D. Bissell, Falck–Ytter, Yngve , Bauer, Seth R , Wieruszewski, Patrick M. , Dugar, Siddharth , Sacha, Gretchen , Sato, Ryota , Siuba, Matthew , Schleicher, Mary , Vachharajani, Vidula , Morgan, Rebecca L.

Mayo Clinic

C39. PNEUMONIA AND SEPSIS: EPIDEMIOLOGY, TREATMENTS, AND OUTCOMES | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A5482-A5482

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5482 Get It

Temporal Trends in Critical Care Utilization and Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Ochal, Domenic, Sklar, David P. , Litzow, Mark R. , Torghabeh, Mehrdad Hefazi, Yadav, Hemang , Heybati, Kiyan , Hogan, William J. , Alkhateeb, Hassan B. , Herasevich, Svetlana , Shah, Meera , Hefazi, Mehrdad , Durani, Urshila , Bauer, Philippe R. , Gajic, Ognjen

Mayo Clinic

A41. REVIEWING ALL THE SYSTEMS: ADVANCES IN NON-PULMONARY CRITICAL CARE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A1543-A1543

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1543 Get It

Mechanical Power-guided Lung Protective Ventilation in Acute Hypoxemic and/or Hypercapnic Respiratory Failure (VentCoach)
Meyer, T. , Baker, J., LeTourneau, William M. , Oeckler, Richard A. , Puentes, G.A. Cortes, Zheng, C., Bauer, Philippe R.

Mayo Clinic

B103. PERSONALIZING CARE FOR PATIENTS WITH ACUTE RESPIRATORY FAILURE | April 30, 2024 | Volume: No volume available | Issue: No issue available | Pages: A4797-A4797

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4797 Get It

How to Make Tracheal Intubation in the ICU Safer and More Effective?*
Jong, Audrey De , Bauer, Philippe R.

Mayo Clinic

Critical Care Medicine | April 15, 2024 | Volume: 52 | Issue: 5 | Pages: 859-862

10.1097/ccm.0000000000006214 | PMID 38619347 Get It

The role of occipital condyle and atlas anomalies on occipital cervical fusion outcomes in Chiari malformation type I with syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium
Koueik, Joyce , Ackerman, Laurie L. , Adelson, P. David , Albert, Gregory W. , Aldana, Philipp R. , Alden, Tord D. , Anderson, Richard C. E. , Bauer, David F. , Bethel-Anderson, Tammy, Bierbrauer, Karin S. , Brockmeyer, Douglas L. , Chern, Joshua J. , Couture, Daniel E., Durham, Susan, Ellenbogen, Richard G. , Eskandari, Ramin , Fuchs, Herbert E., Greene, Stephanie , Gross, Naina L. , Guillaume, Daniel, Hankinson, Todd C. , Heuer, Gregory G. , Iantosca, Mark, Iskandar, Bermans J. , Kaufman, Bruce A., Keating, Robert F., Krieger, Mark D., Leonard, Jeffrey R. , Maher, Cormac O. , Mangano, Francesco T. , Martin, Jonathan E. , McComb, J. Gordon , McEvoy, Sean D., Meehan, Thanda, Muhlbauer, Michael S., O’Neill, Brent R., Olavarria, Greg, Ragheb, John , Shannon, Chevis N. , Stone, Scellig , Strahle, Jennifer M. , Tamber, Mandeep S. , Torner, James C., Tuite, Gerald F. , Tyler‐Kabara, Elizabeth C. , Wait, Scott D. , Wellons, John C. , Whitehead, William E. , Limbrick, David D. , Torner, James C. , Yahanda, Alexander T. , Daniels, David J. , Dlouhy, Brian J , Grant, Gerald A. , Graupman, Patrick C. , Greenfield, Jeffrey P. , Guillaume, Daniel J., Jackson, Eric M. , Jallo, George I. , Johnston, James M. , Khan, Nickalus R. , Menezes, Arnold H. , Selden, Nathan R. W. , Shah, Manish N. , Shimony, Joshua S. , Park, Tae Sung , Limbrick, David D. , Ahmed, Raheel

Mayo Clinic

Journal of Neurosurgery: Pediatrics | April 6, 2024 | Volume: 34 | Issue: 1 | Pages: 66-74

10.3171/2024.1.peds23229 | PMID 38579359 Get It

OBJECTIVE Congenital anomalies of the atlanto-occipital articulation may be present in patients with Chiari malformation type I (CM-I). However, it is unclear how these anomalies affect the biomechanical stability of the craniovertebral junction (CVJ) and whether they are associated with an increased incidence of occipitocervical fusion (OCF) following posterior fossa decompression (PFD). The objective of this study was to determine the prevalence of condylar hypoplasia and atlas anomalies in children with CM-I and syringomyelia. The authors also investigated the predictive contribution of these anomalies to the occurrence of OCF following PFD (PFD+OCF). METHODS The authors analyzed the prevalence of condylar hypoplasia and atlas arch anomalies for patients in the Park-Reeves Syringomyelia Research Consortium database who underwent PFD+OCF. Condylar hypoplasia was defined by an atlanto-occipital joint axis angle (AOJAA) ≥ 130°. Atlas assimilation and arch anomalies were identified on presurgical radiographic imaging. This PFD+OCF cohort was compared with a control cohort of patients who underwent PFD alone. The control group was matched to the PFD+OCF cohort according to age, sex, and duration of symptoms at a 2:1 ratio. RESULTS Clinical features and radiographic atlanto-occipital joint parameters were compared between 19 patients in the PFD+OCF cohort and 38 patients in the PFD-only cohort. Demographic data were not significantly different between cohorts (p > 0.05). The mean AOJAA was significantly higher in the PFD+OCF group than in the PFD group (144° ± 12° vs 127° ± 6°, p < 0.0001). In the PFD+OCF group, atlas assimilation and atlas arch anomalies were identified in 10 (53%) and 5 (26%) patients, respectively. These anomalies were absent (n = 0) in the PFD group (p < 0.001). Multivariate regression analysis identified the following 3 CVJ radiographic variables that were predictive of OCF occurrence after PFD: AOJAA ≥ 130° (p = 0.01), clivoaxial angle < 125° (p = 0.02), and occipital condyle–C2 sagittal vertical alignment (C–C2SVA) ≥ 5 mm (p = 0.01). A predictive model based on these 3 factors accurately predicted OCF following PFD (C-statistic 0.95). CONCLUSIONS The authors’ results indicate that the occipital condyle–atlas joint complex might affect the biomechanical integrity of the CVJ in children with CM-I and syringomyelia. They describe the role of the AOJAA metric as an independent predictive factor for occurrence of OCF following PFD. Preoperative identification of these skeletal abnormalities may be used to guide surgical planning and treatment of patients with complex CM-I and coexistent osseous pathology.
MR elastography–based slip interface imaging (SII) for functional assessment of myofascial interfaces: A feasibility study
Hojo, Emi , Sui, Yi , Shan, Xiang , Rossman, Phillip J. , Manduca, Armando , Powell, Garret M. , An, Kai‐Nan, Zhao, Kristin D. , Bauer, Brent A. , Yin, Ziying , Zheng, Keni, Rossman, Phillip, Manduca, A , Ehman, Richard , Yin, Ziying , Trentadue, Taylor P , Sui, Yi , Hojo, Emi , Zheng, Keni , An, Kai‐Nan , Ehman, Richard L.

Mayo Clinic

Magnetic Resonance in Medicine | March 25, 2024 | Volume: 92 | Issue: 2 | Pages: 676-687

10.1002/mrm.30087 | PMID 38523575 Get It

AbstractPurposeAbnormal adherence at functional myofascial interfaces is hypothesized as an important phenomenon in myofascial pain syndrome. This study aimed to investigate the feasibility of MR elastography (MRE)–based slip interface imaging (SII) to visualize and assess myofascial mobility in healthy volunteers.MethodsSII was used to assess local shear strain at functional myofascial interfaces in the flexor digitorum profundus (FDP) and thighs. In the FDP, MRE was performed at 90 Hz vibration to each index, middle, ring, and little finger. Two thigh MRE scans were performed at 40 Hz with knees flexed and extended. The normalized octahedral shear strain (NOSS) maps were calculated to visualize myofascial slip interfaces. The entropy of the probability distribution of the gradient NOSS was computed for the two knee positions at the intermuscular interface between vastus lateralis and vastus intermedius, around rectus femoris, and between vastus intermedius and vastus medialis.ResultsNOSS map depicted distinct functional slip interfaces in the FDP for each finger. Compared to knee flexion, clearer slip interfaces and larger gradient NOSS entropy at the vastus lateralis–vastus intermedius interface were observed during knee extension, where the quadriceps are not passively stretched. This suggests the optimal position for using SII to visualize myofascial slip interface in skeletal muscles is when muscles are not subjected to any additional force.ConclusionThe study demonstrated that MRE‐based SII can visualize and assess myofascial interface mobility in extremities. The results provide a foundation for investigating the hypothesis that myofascial pain syndrome is characterized by changes in the mobility of myofascial interfaces.